Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 25-Mar-24 11:05 AM View:  | Leonard Braden Michael 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 20-Mar-24 | Private Purchase | 170,589 | $2.95 | $503,238.00 | 4% 3.82M to 3.99M | |
| 19-Mar-24 4:19 PM View: | Leonard Braden Michael 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 18-Mar-24 | Private Purchase | 113,777 | $3.01 | $342,469.00 | 3% 3.7M to 3.82M | |
| 05-Mar-24 6:11 PM View: | Gaiero David G Chief Financial Officer | Cyteir Therapeutics, Inc. (CYT) | 04-Mar-24 | Option Exercise | 2,373 | $1.69 | $4,010.37 | 2% 100.02K to 102.39K | |
| 05-Mar-24 6:10 PM View: | Renschler Markus Md President and CEO Director | Cyteir Therapeutics, Inc. (CYT) | 04-Mar-24 | Option Exercise | 6,304 | $1.69 | $10,653.80 | < 1% 1.1M to 1.1M | |
| 05-Mar-24 6:11 PM View: | Gaiero David G Chief Financial Officer | Cyteir Therapeutics, Inc. (CYT) | 29-Feb-24 | Option Exercise | 7,985 | $1.69 | $13,462.30 | 9% 92.03K to 100.02K | |
| 05-Mar-24 6:10 PM View: | Renschler Markus Md President and CEO Director | Cyteir Therapeutics, Inc. (CYT) | 29-Feb-24 | Option Exercise | 15,144 | $1.61 | $24,350.20 | 1% 1.08M to 1.1M | |
| 16-Feb-24 4:00 PM View: | George Jean Director | Cyteir Therapeutics, Inc. (CYT) | 14-Feb-24 | Option Exercise | 14,150 | $1.69 | $23,913.50 | < 1% 2.44M to 2.46M | |
| 14-Feb-24 10:00 PM View: | Sands Stephen H. Director | Cyteir Therapeutics, Inc. (CYT) | 09-Feb-24 | Option Exercise | 12,129 | $1.69 | $20,498.00 | 100% 0 to 12.13K | |
| 12-Feb-24 4:00 PM View: | Thero John F Director | Cyteir Therapeutics, Inc. (CYT) | 08-Feb-24 | Option Exercise | 12,828 | $1.69 | $21,679.30 | 128% 10.0K to 22.83K | |
| 08-Feb-24 4:11 PM View: | Zakrzewski Joseph S Director | Cyteir Therapeutics, Inc. (CYT) | 06-Feb-24 | Option Exercise | 14,150 | $1.69 | $23,913.50 | 4% 362.34K to 376.49K | |
| 14-Dec-23 4:00 PM View: | Gaiero David G Chief Financial Officer | Cyteir Therapeutics, Inc. (CYT) | 11-Dec-23 | Option Exercise | 3,993 | $1.69 | $6,731.97 | 5% 88.04K to 92.03K | |
| 14-Dec-23 4:00 PM View: | Renschler Markus Md President and CEO Director | Cyteir Therapeutics, Inc. (CYT) | 20-Nov-23 | Option Exercise | 8,840 | $1.55 | $13,697.00 | < 1% 1.07M to 1.08M | |
| 22-Nov-23 1:47 PM View: | Gaiero David G Chief Financial Officer | Cyteir Therapeutics, Inc. (CYT) | 20-Nov-23 | Option Exercise | 73,940 | $1.68 | $124,433.00 | 524% 14.1K to 88.04K | |
| 22-Nov-23 1:48 PM View: | Renschler Markus Md President and CEO Director | Cyteir Therapeutics, Inc. (CYT) | 20-Nov-23 | Option Exercise | 84,637 | $1.53 | $129,366.00 | 9% 988.73K to 1.07M | |
| 20-Jul-23 8:01 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 20-Jul-23 | Sale | 100,000 | $2.75 | $275,140.00 | (3%) 3.62M to 3.52M | |
| 20-Jul-23 8:01 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 19-Jul-23 | Sale | 1,900 | $2.76 | $5,247.04 | (< 1%) 3.62M to 3.62M | |
| 18-Jul-23 8:27 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 18-Jul-23 | Sale | 6,500 | $2.76 | $17,923.10 | (< 1%) 3.63M to 3.62M | |
| 18-Jul-23 8:27 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 17-Jul-23 | Sale | 21,100 | $2.75 | $57,999.70 | (< 1%) 3.65M to 3.63M | |
| 18-Jul-23 8:27 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 14-Jul-23 | Sale | 11,000 | $2.74 | $30,101.50 | (< 1%) 3.66M to 3.65M | |
| 03-Jul-23 6:29 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 30-Jun-23 | Sale | 200,937 | $2.63 | $529,288.00 | (5%) 3.86M to 3.66M | |
| 28-Jun-23 9:35 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 27-Jun-23 | Sale | 31,978 | $1.77 | $56,687.40 | (< 1%) 3.9M to 3.86M | |
| 28-Jun-23 9:35 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 26-Jun-23 | Sale | 8,437 | $1.79 | $15,106.40 | (< 1%) 3.9M to 3.9M | |
| 23-Jun-23 7:17 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 23-Jun-23 | Sale | 3,423 | $1.88 | $6,446.88 | (< 1%) 3.91M to 3.9M | |
| 23-Jun-23 7:17 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 22-Jun-23 | Sale | 5,041 | $1.94 | $9,782.56 | (< 1%) 3.91M to 3.91M | |
| 23-Jun-23 7:17 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 21-Jun-23 | Sale | 4,834 | $1.99 | $9,640.93 | (< 1%) 3.92M to 3.91M | |
| 14-Jun-23 8:18 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 14-Jun-23 | Sale | 2,872 | $2.11 | $6,050.16 | (< 1%) 3.94M to 3.93M | |
| 14-Jun-23 8:18 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 13-Jun-23 | Sale | 2,626 | $2.10 | $5,514.60 | (< 1%) 3.94M to 3.94M | |
| 14-Jun-23 8:18 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 12-Jun-23 | Sale | 900 | $2.06 | $1,858.05 | (< 1%) 3.94M to 3.94M | |
| 07-Feb-23 4:41 PM View: | Gaiero David G Chief Financial Officer | Cyteir Therapeutics, Inc. (CYT) | 13-Jan-23 | Grant | 5,000 | $1.49 | $7,450.00 | 122% 4.1K to 9.1K | |
| 07-Feb-23 4:08 PM View: | Renschler Markus Md President and CEO Director | Cyteir Therapeutics, Inc. (CYT) | 13-Jan-23 | Grant | 5,000 | $1.49 | $7,450.00 | < 1% 978.74K to 983.74K | |
| 23-Dec-22 4:47 PM View: | Renschler Markus Md President and CEO Director | Cyteir Therapeutics, Inc. (CYT) | 21-Dec-22 | Option Exercise | 136,782 | $1.07 | $146,060.00 | 16% 841.95K to 978.74K | |
| 08-Dec-22 5:09 PM View: | Zakrzewski Joseph S Director | Cyteir Therapeutics, Inc. (CYT) | 07-Dec-22 | Private Purchase | 21,202 | $1.30 | $27,562.60 | 6% 341.14K to 362.34K | |
| 22-Jul-22 6:52 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 20-Jul-22 | Sale | 900,000 | $3.00 | $2,700,000.00 | (19%) 4.84M to 3.94M | |
| 16-May-22 4:24 PM View: | Zakrzewski Joseph S Director | Cyteir Therapeutics, Inc. (CYT) | 12-May-22 | Private Purchase | 743 | $1.61 | $1,196.23 | < 1% 340.39K to 341.14K | |
| 12-May-22 4:35 PM View: | Zakrzewski Joseph S Director | Cyteir Therapeutics, Inc. (CYT) | 11-May-22 | Purchase | 1,000 | $1.70 | $1,700.00 | < 1% 339.39K to 340.39K | |
| 12-May-22 4:35 PM View: | Zakrzewski Joseph S Director | Cyteir Therapeutics, Inc. (CYT) | 10-May-22 | Private Purchase | 49,406 | $1.89 | $93,377.30 | 17% 289.99K to 339.39K | |
| 12-May-22 4:38 PM View: | Thero John F Director | Cyteir Therapeutics, Inc. (CYT) | 10-May-22 | Private Purchase | 10,000 | $2.00 | $20,000.00 | 100% 0 to 10.0K | |
| 28-Dec-21 6:24 PM View: | Zakrzewski Joseph S Director | Cyteir Therapeutics, Inc. (CYT) | 28-Dec-21 | Market Purchase | 601 | $9.85 | $5,919.85 | < 1% 289.39K to 289.99K | |
| 28-Dec-21 6:24 PM View: | Zakrzewski Joseph S Director | Cyteir Therapeutics, Inc. (CYT) | 27-Dec-21 | Market Purchase | 299 | $10.04 | $3,001.82 | < 1% 289.09K to 289.39K | |
| 28-Dec-21 6:24 PM View: | Zakrzewski Joseph S Director | Cyteir Therapeutics, Inc. (CYT) | 23-Dec-21 | Private Purchase | 200 | $9.87 | $1,974.00 | < 1% 288.89K to 289.09K | |
| 07-Feb-23 4:38 PM View: | Gaiero David G Chief Financial Officer | Cyteir Therapeutics, Inc. (CYT) | 20-Dec-21 | Option Exercise | 4,100 | $1.68 | $6,888.00 | 100% 0 to 4.1K | |
| 21-Dec-21 6:06 PM View: | Zakrzewski Joseph S Director | Cyteir Therapeutics, Inc. (CYT) | 17-Dec-21 | Market Purchase | 200 | $9.88 | $1,976.00 | < 1% 288.69K to 288.89K | 11% |
| 15-Dec-21 8:09 PM View: | Zakrzewski Joseph S Director | Cyteir Therapeutics, Inc. (CYT) | 15-Dec-21 | Market Purchase | 3,700 | $10.77 | $39,844.00 | 1% 284.99K to 288.69K | (< 1%) |
| 24-Jun-21 8:55 PM View: | Droia Invest II Scsp 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 22-Jun-21 | Conversion | 3,259,030 | -- | -- | 100% 0 to 3.26M | |
| 23-Jun-21 5:18 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 22-Jun-21 | Conversion | 4,562,640 | -- | -- | 100% 0 to 4.56M | |
| 24-Jun-21 8:50 PM View: | Naesens Janwillem Director | Cyteir Therapeutics, Inc. (CYT) | 22-Jun-21 | Conversion Duplicate | 3,259,030 | -- | -- | 100% 0 to 3.26M | |
| 24-Jun-21 8:54 PM View: | Zakrzewski Joseph S Director | Cyteir Therapeutics, Inc. (CYT) | 22-Jun-21 | Conversion | 58,671 | -- | -- | 26% 226.32K to 284.99K | |
| 24-Jun-21 8:55 PM View: | Droia Invest II Scsp 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 22-Jun-21 | Market Purchase | 277,777 | $18.00 | $4,999,990.00 | 9% 3.26M to 3.54M | (40%) |
| 23-Jun-21 5:18 PM View: | Novo A/s 10% Owner | Cyteir Therapeutics, Inc. (CYT) | 22-Jun-21 | Market Purchase | 277,777 | $18.00 | $4,999,990.00 | 6% 4.56M to 4.84M | (40%) |
| 24-Jun-21 8:48 PM View: | George Jean Director | Cyteir Therapeutics, Inc. (CYT) | 22-Jun-21 | Conversion | 2,444,270 | -- | -- | 100% 0 to 2.44M |
